@platinumstandard did set the record, errm, straight: to classify AVR as a biotech stock is just plain wrong.
I assume the Anteris Wikipedia page is written by Anteris' publicity, or at the very least monitored by them: From Wikipedia, the free encyclopedia Anteris Technologies Limited is an Australian biotechnology company.
I could cite other sources, but If Anteris is not a Australian Biotech then I have failed to grasp the meaning of either word. As for the opinion I expressed about risk etc, I stand by that too.
Regards, P
AVR Price at posting:
$19.57 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)